Prothea debuts with $13m to develop cancer diagnostics and treatment
Prothea plans to use the funds to start clinical trial for cancer imaging, biopsy and laser ablation treatment in lung cancer patients.
Medical Devices
Alebund receives ODD for investigational drug AP303
NVIDIA doubles down on AI in healthcare with drug discovery deals
Setting up trials in APAC and Middle East can boost patient recruitment
FluoGuide imaging agent wins FDA orphan drug designation for glioma surgery
FDA approves Empaveli injector for PNH patients
Sun rises on Lithuania’s life sciences industry
Pharmaceutical Technology Excellence Awards 2022: NTI – Northgate Technologies
